Stay updated on Pembrolizumab Combo in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cervical Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a Locations section including Florida. Removed the Florida Locations entry in the footer and updated the revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to study content such as eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe operating status notice about government funding has been removed from the page. The study details remain unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedAdded a Results section with primary and secondary outcomes and safety data, and updated the results posting date.SummaryDifference0.4%

- Check104 days agoChange DetectedKey updates: add an important operating-status notice and a new version tag (v3.2.0); remove the old version tag (v3.1.0).SummaryDifference3%

Stay in the know with updates to Pembrolizumab Combo in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cervical Cancer Clinical Trial page.